Introduction: The use of topical haemostatic agents has been popularised in recent years in many areas of surgery. We aimed to determine whether Ankaferd blood stopper ® (ABS) can shorten the bleeding time and decrease the amount of bleeding in a rat abdominal aortic bleeding model.
INTRODUCTION
The use of topical haemostatic agents has been popularised in recent years in many areas of surgery, because these agents facilitate cessation of minor bleeding during surgery. Such topical agents are especially used when bleeding is uncontrollable with common methods, such as suturing, ligation or cauterization. Several topical haemostatic agents such as topical gelatines, collagen preparations, oxidized celluloses, fi brin sealants, synthetic glues and glutaraldehyde-based glues have been suggested to be useful in various clinical like gastrointestinal bleeding and in some surgical bleeding like usage of fi brin glue in vascular surgery. Despite numerous clinical studies, the use of these topical agents has not been introduced in routine clinical practice due to a lack of randomised clinical trials (1, 2) . Ankaferd blood stopper ® (ABS) is a herbal extract that comprises a standard mixture of various plants, each with benefi cial features on cellular proliferation, endothelial functions, angiogenesis or vascular dynamics (3) . ABS achieves haemostasis basically by agglutination and polymerization that modulates plasma protein, especially fi brinogen aggregation, within the endothelium and the vascular wall. These and other important features of ABS, such as having vasoactive functions as reported by an experimental study, make it an ideal haemostatic agent in vascular surgery (4) . Despite its use being tested even in experimental vascular anastomosis models, there is limited knowledge that justifi es its routine use in different areas of vascular surgery.
Oozing or ongoing bleeding during aortic surgery is troublesome. In this experimental study, we aimed to determine that ABS can shorten the bleeding time and decrease the amount of bleeding in a rat abdominal aortic bleeding model.
PATIENTS and METHODS
The study was approved by the Committee for Animal Research at Erzincan University, Faculty of Medicine. The experimental protocol was based on a comparison of the bleeding time of rats in whom ABS-(Trend Teknoloji Ilac AS, Istanbul, Turkey) or normal saline-soaked gauzes were used to stop bleeding over incised abdominal aorta. All experimental protocols were in accordance with the guidelines for the Care and Use of Laboratory Animals prepared by the US National Academy of Sciences and published by the US National Institute of Health (NIH Publications, No: 80-23). All animals were treated in compliance with the 'Principles of Laboratory Animal Care' formulated by the National Society for Medical Research.
In this study, Wistar-albino rats, aged between 9 and 18 months (mean 13.8 ± 3.3 months) and weighing between 100 and 150 g (mean 123 ± 23 g) were used. Rats were obtained from Erzincan University Health Sciences Application and Research Center. The animals were housed in standard environmental conditions with a humidity of 45-50%, daylight/dark cycle of 12/12 h and room temperature of 21 ± 2°C. The animals were fed with a consistent normal rat feed and given fresh water each day. Rats were deprived of food but allowed to have water 24 h before surgery. All efforts were made to minimise animal suffering and distress.
Rats were randomly divided into four experimental groups: normal saline-soaked gauzes were applied to rats in Group 1 (n= 10) and ABS-soaked gauzes were applied to rats in Group 2 (n= 10); both Group 1 and Group 2 rats had not undergone any pre-treatment. Normal saline-soaked gauzes were applied to rats receiving oral acetylsalicylic acid at a dose of 30 mg/kg/day plus oral clopidrogel at a dose of 10 mg/kg/day for 5 days in Group 3 (n= 10), and ABS-soaked gauzes were applied to rats in Group 4 (n= 10) with the same pre-treatment given in Group 3.
Before the surgical procedure, rats were anaesthetised with 75 mg/kg of intramuscular ketamine and laid in a supine position on a pad. A 10% povidone-iodine solution was applied over the skin and a midline abdominal incision was made. Abdominal aorta was explored and 3 mL blood samples were taken from the abdominal aorta to measure the levels of red blood cell (RBC), haemoglobin (Hb), hematocrit (Hct) and platelets and coagulation parameters [prothrombin time (PT) and activated partial thromboplastin time (aPTT)]. Subsequently, an incision of about 1 mm was made over the anterior surface of the aorta just proximal to the iliac bifurcation with a fue punch (Ertıp Turkey). Either ABS-or saline-soaked gauze tampons were kept directly compressed over the wound with a 20-g weight. The weight was removed from the wound in every 10 seconds until bleeding stopped. The time taken until the bleeding stopped was recorded. The amount of bleeding was determined by weighing the gauzes on precision scales by subtracting their tare weights. All animals were sacrifi ced by cervical dislocation on the day of the surgery.
Statistical Analysis
All statistical analyses were performed using SPSS (version 16.0 Inc. Chicago, IL. USA). Histograms and Shapiro-Wilks test were used for determination of normal distribution. Continuous data were defi ned as mean ± standard deviations. Parametric data were compared using independent sample t-test and nonparametric data using Mann-Whitney test. Categorical data were compared using chi-square test or Fisher's exact test, where appropriate. Non-parametric Kruskal-Wallis test was used to compare the groups for dependent variables due to the low number of the groups (n< 30), and a non-parametric test of correlation (Spearman's) was used for correlation analysis. A p value of < 0.05 was considered to be statistically signifi cant.
RESULTS
The mean RBC, platelet count (Hb, Hct, aPTT, PT levels) and weights of the rats in all the groups are summarised in Table  1 , in which there was no signifi cant difference between the groups (p> 0.05). A comparison of the bleeding time and amount of bleeding between the groups treated or untreated with ABS is given in Table 2 . When Group 1 and 2 rats were compared, the mean bleeding time (MBT) was signifi cantly shorter in ABStreated rats (Group 2) than in saline-treated rats (Group 1) (1.50 ± 0:40 and 1:19 ± 0.10 min for Groups 1 and 2, respectively, p= 0.0257). MBT was signifi cantly higher in rats who underwent acetylsalicylic acid and clopidogrel therapy (Groups 3 and 4) in comparison with rats in the untreated groups (Groups 1 and 2) (p< 0.05). In addition, MBT values of Group 3 were considerably longer than those of Group 4 (4.70 ± 2:53 and 2.71 ± 1.11 min for Groups 3 and 4, respectively, p= 0.0232) (Figure 1) . Likewise, Group 2 compared to Group 1 and Group 4 compared to Group 3 had signifi cantly lower mean bleeding amount (MBA) (4:06 ± 1.83 versus 1.90 ± 0.60 mg for Groups 1 and 2, respectively, p= 0.0039 and 4.68 ± 1.82 versus 2.75 ± 0.68 mg for Groups 3 and 4, respectively, p= 0.0029) (Figure 2 ). In the Spearman correlation analysis covering all groups, there was a moderate positive correlation between MBT and MBA values (r= 0.5604, p< 0.0002) (Figure 3 ).
DISCUSSION
We observed that the topical use of ABS shortened the time required to stop bleeding through an incision on the abdominal aorta even in case of a delayed coagulation due to anticoagulants given before the surgical experiment. The effect size of the difference between the groups that did not receive pre-treatment was only about 30 s, which seems to be of minimal clinical relevance. However, the use of ABS nearly halved the bleeding time in the groups that received pre-treatment, indicating that it has a potential to be used in the vascular surgery as required in patients receiving anticoagulant drugs preoperatively.
There have only been few experimental studies on the use of ABS in the area of vascular surgery although minor oozing bleeding and unpredictable post-operative blood loss are of major concern. Kandemir et al. conducted a study investigating the effect of ABS on the abdominal aortic bleeding model (5) . Similar to us, these authors compared the bleeding times between rats receiving either ABS-soaked or normal gauzes for compression over the bleeding aorta and reported that the ABS-applied group had 36.7% shorter bleeding time as compared to the control group. In addition, in the histopathologic fi ndings recorded on the seventh day after the surgery, they observed that the vascular endothelial cell loss and the infl ammatory response did not differ signifi cantly among the groups. In another recent animal study, Abacıoglu et al. randomised 30 rats who would receive either ABS or chitosan linear polymer or serve as controls (6) . By performing an incision over the femoral artery and recording the time until the bleeding stopped, the authors reported that two topical anticoagulants were similar to each other with regard to the bleeding times, but both were provided with shorter times as compared to the controls.
Yesilada et al. created a model where they divided and re-anastomosed the femoral arteries of 14 rats (7) . Half of the subjects were treated with ABS, and the authors reported that its use was associated with a signifi cant decrease in the anastomosis completion time whilst macroscopic and microscopic patency, the existence of micro-aneurysm and infl ammatory response was similar to the controls. On the contrary, Sacak et al. similarly divided and then re-anastomosed the femoral arteries of 21 Wistar-albino rats (8) . Further, they were randomly allocated to receive saline or ABS after the surgery. Two of the three groups were also pre-treated with acetylsalicylic acid. The results of that study were intriguing; ABS application provided shorter bleeding times in rats but all the rats that received ABS developed a tunica media degeneration and a contraction of tunica intima leading to an aneurysm formation in the anastomosis sites. Thus, the authors recommended against the use of ABS in the anastomosed vessels.
Besides several experimental studies, there have also been many clinical reports on the use of ABS in various areas of surgery with dental surgical procedures and relatively minor surgical fi elds being far more common. In a study on 25 patients, it was reported that the use of ABS in patients on antithrombotic therapy eliminated the need for the discontinuation of the antithrombotic drug before dental surgery, because it caused a signifi cant decrease in the bleeding time as compared to controls (9) . In a larger group by Beyazit et al. using the spray form of ABS in 113 dental extractions, it was reported that ABS stopped bleeding less than 10 s in nearly half of the patients (10) . Iynen et al. conducted a prospective randomised study using ABS on patients receiving cold steel adenoidectomy (11) . The authors reported that ABS provided signifi cantly shorter operative time, less blood loss during the surgery and shorter haemostasis. In another study, Guler et al. randomised the patients who underwent total thyroidectomy into ABS or a conventional technique for oozing-type bleeding and reported that the postoperative amount of drained blood was signifi cantly lower in the ABS group (12) . Teker et al. conducted a randomised study on patients with anterior epistaxis and reported interesting results: ABS provided better haemostasis than phenylephrine (79.2% vs. 64.0%, p< 0.05); moreover, 44.0% patients who crossed over from phenylephrine to ABS achieved haemostasis (13) . The number of re-bleeding rats was also signifi cantly lower in the ABS group.
Although there have been placebo-controlled, prospective randomised studies on the use of ABS even in the setting of cardiac surgery, its safety is still a major concern. Turhan et al. injected one millilitre of ABS into systemic circulation of 12 rabbits (14) . Two rabbits died within 5 min of administration. A post-mortem histopathological examination revealed a hepatic venous outfl ow obstruction, indicating a potential life-threatening effect of even a small amount of the drug. Nazlı et al. applied ABS-soaked sponges over the abraded epicardium of 16 white rabbits to test whether ABS prevents post-operative pericardial adhesions (15) . The authors reported that ABS did not prevent the adhesions but caused the formation of pericardial adhesions and fi brosis. On the contrary, Mihmanli et al. evaluated its cytotoxicity on human cultured blood cells and concluded that ABS can be safely used as an alternative blood stopping agent (16) .
Our study is limited with a lack of adequate data to evaluate the effectiveness of ABS in controlling bleeding from the aortic tissue after anastomosed with native or synthetic tissues, such as Dacron or PTFE grafts. Our data was based on short-term results, and undoubtedly, a later evaluation should provide important knowledge.
CONCLUSION
In conclusion, ABS has the potential to reduce the bleeding time and post-operative blood loss after a major aortic surgery. However, its safety should be well-established before undertaking large-scale clinical studies in the area of vascular surgery.
